Literature DB >> 492702

Correlation of pharyngeal fistulization with preoperative radiotherapy, reduced serum albumen, and dietary obstruction.

P J Gullane, J M Jabbour, J J Conley, T F Nealon.   

Abstract

The clinical courses of patients on the Head and Neck Service undergoing radical procedures were reviewed in retrospect. Factors that appeared to influence the courses such as preoperative radiotherapy, reduced serum albumen, and preoperative oropharyngeal obstruction were correlated with fistulization rate, flap necrosis, and other complications. The study included 105 radical procedures performed over a seven-month period. Sixty-six of these operations included laryngectomies, laryngopharyngectomies, and composite resections. The overall complication rate was 37%, with major complications accounting for 9%. A fistula rate of 20% was found in the pharyngeal group and ranged from 12% in the nonirradiated patients to 44% in the irradiated group. Thos patients with preoperative obstruction secondary to tumor bulk had a complication rate of 58%. Patients with reduced serum albumen levels had a higher complication rate of 55% compared with 35% for the group with normal albumen levels. This study suggests that preoperative replenishment of protein, particularly in the obstructed patient or in those with reduced serum albumen levels, would correlate with a more favorable clinical course.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 492702     DOI: 10.1177/019459987908700306

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg (1979)


  2 in total

Review 1.  Transoral robotic surgery and a paradigm shift in the management of oropharyngeal squamous cell carcinoma.

Authors:  Harry Quon; Bert W O'Malley; Gregory S Weinstein
Journal:  J Robot Surg       Date:  2010-06-29

2.  Oral feeding after total laryngectomy for endolaryngeal cancer.

Authors:  S Rodríguez-Cuevas; S Labastida; F Gutierrez; F Granados
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.